JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YONG, M. S.
Right arrow Articles by NICKERSON, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YONG, M. S.
Right arrow Articles by NICKERSON, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 186, Issue 1, 100-108, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics

DISSOCIATION OF ALPHA ADRENERGIC RECEPTOR PROTECTION FROM INHIBITION OF 3H-PHENOXYBENZAMINE BINDING IN VASCULAR TISSUE

MAN SEN YONG 1 and MARK NICKERSON 2

1 Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
2 Department of Pharmacology and Therapeutics, McGill university, Montreal, Quebec, Canada

3H-phenoxybenzamine (3H-POB) of high specific activity was synthesized, and its alpha adrenergic blocking action and tissue binding were studied in parallel on strips of rabbit thoracie aorta. The presence of a sympathomimetic amine could decrease both the blocking action and the bound radioactivity, but the two effects were not parallel. Epinephrine and agr-methylnorepinephrine most effectively protected the receptors but decreased binding no more than did norepinephrine or isoproterenol. Only catecholamines (all of six tested) reduced binding significantly. Dopamine and agr-methyldopamine decreased binding in the absence of significant receptor protection. Conversely, alpha and beta. adrenergic blocking agents markedly decreased the POB block without a decrease in bound radioactivity. Inhibition of both monoamine oxidase and catechol-O-methyltransferase affected binding more than blockade, perhaps due to a localized accumulation of catecholamine. It is concluded that apha adrenergic receptors represent too small a fraction of total bound POB for their protection to be detected as a decrease in binding, even with 3H-POB of high specific activity. The major decrease in binding appeared to involve "silent receptors" that are quite specific for catecholamines. This site could not be equated with any of those now known to be involved in catecholamine action or inactivation. However, it is of sufficient capacity, up to 45% of the total 3H-POB bound in the present experiments, to have an important effect on catecholamine action.

Submitted on July 17, 1972
Accepted on February 26, 1973




This article has been cited by other articles:


Home page
 ScienceHome page
L. Williams and R. Lefkowitz
Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding
Science, May 21, 1976; 192(4241): 791 - 793.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.